You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Eplerenone - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for eplerenone and what is the scope of freedom to operate?

Eplerenone is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Annora Pharma, Breckenridge, Chartwell Rx, Prasco, Rising, Sandoz, Slate Run Pharma, Westminster Pharms, and Upjohn, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for eplerenone. Twelve suppliers are listed for this compound.

Summary for eplerenone

US Patents:	0
Tradenames:	2
Applicants:	10
NDAs:	10
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	12
Raw Ingredient (Bulk) Api Vendors:	61
Clinical Trials:	127
Patent Applications:	5,635
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for eplerenone
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for eplerenone
What excipients (inactive ingredients) are in eplerenone?	eplerenone excipients list
DailyMed Link:	eplerenone at DailyMed

See drug prices for eplerenone

Recent Clinical Trials for eplerenone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vifor Pharma	Phase 3
Mario Negri Institute for Pharmacological Research	Phase 3
Umeå University	N/A

See all eplerenone clinical trials

Pharmacology for eplerenone

Drug Class	Aldosterone Antagonist
Mechanism of Action	Aldosterone Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for eplerenone

C03DA	Aldosterone antagonists
C03D	ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
C03	DIURETICS
C	Cardiovascular system

Paragraph IV (Patent) Challenges for EPLERENONE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
INSPRA	Injection	eplerenone	0.75 mg/mL, 100 mL vial	021437	1	2009-06-05
INSPRA	Tablets	eplerenone	25 mg and 50 mg	021437	2	2006-09-27

US Patents and Regulatory Information for eplerenone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	EPLERENONE	eplerenone	TABLET;ORAL	078482-002	Jul 30, 2008	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Accord Hlthcare	EPLERENONE	eplerenone	TABLET;ORAL	206922-001	Jul 13, 2017	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-003	Sep 27, 2002		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Slate Run Pharma	EPLERENONE	eplerenone	TABLET;ORAL	212765-001	Aug 10, 2020	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	EPLERENONE	eplerenone	TABLET;ORAL	078482-001	Jul 30, 2008	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for eplerenone

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-001	Sep 27, 2002	⤷ Try a Trial	⤷ Try a Trial
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-001	Sep 27, 2002	⤷ Try a Trial	⤷ Try a Trial
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-002	Sep 27, 2002	⤷ Try a Trial	⤷ Try a Trial
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-001	Sep 27, 2002	⤷ Try a Trial	⤷ Try a Trial
Upjohn	INSPRA	eplerenone	TABLET;ORAL	021437-003	Sep 27, 2002	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.